Hazards of Baby Powder

PEDIATRICS ◽  
1986 ◽  
Vol 78 (3) ◽  
pp. 546-547
Author(s):  
HOWARD C. MOFENSON ◽  
THOMAS R. CARACCIO ◽  
SHARON OKUN ◽  
JOSEPH GREENSHER

To the Editor.— In a recent letter to the editor, Cotton and Davidson1 have brought the hazards of baby powder aspiration to the attention of the medical community. We have been monitoring episodes of possible powder inhalation and ingestion in our community (population 3 million) since 1980, when two infants were hospitalized [See table in the PDF file] for powder aspiration and one required ventilator therapy for two days. Our recent data (Table) shows a progressive decrease in the number of possible inhalations and ingestion episodes since 1981 when our article2 was published in Pediatrics and the American Academy of Pediatrics publicized the hazard of baby powder.

PEDIATRICS ◽  
1971 ◽  
Vol 47 (2) ◽  
pp. 465-469
Author(s):  
Russell W. Mapes

For any national organization striving to keep pace with increasingly diverse responsibilities and objectives, there are appropriate times when that organization must pause, reflect, and project before moving forward to meet the goals to which it has dedicated its programs and priorities. This year marks the 40th anniversary of the American Academy of Pediatrics. It was June 23, 1930 that 35 pediatricians met in Harper Hospital in Detroit to establish the Academy as the organization to speak for the interests and health of children, as well as the interests of its pediatric members. This year also marks the beginning of a new decade, a decade which holds great promise for the future of pediatrics but a decade which also presents significant challenges which we must meet if we are to deliver quality health care to all children. The American Academy of Pediatrics is indeed fortunate to be able to draw from the accomplishments of a progressive history of achievement, distinguished by the vision of its early founders. In the 1920's the medical community widely predicted that pediatrics was disappearing as a specialty, that in a few years it would merge into the field of general medicine. Concern was also expressed that pediatrics was not sufficiently represented in the echelons of organized medicine and, consequently, the cause of child health was not being served adequately. To pediatricians like Isaac A. Abt, the first president of the Academy, to John L. Morse, its first vice-president, and to Clifford G. Grulee, the Academy's pioneering executive director, these were very real challenges, but they were not causes for pessimism or defeatism.


PEDIATRICS ◽  
1974 ◽  
Vol 53 (6) ◽  
pp. 952-953
Author(s):  
Samuel Livingston ◽  
Wulfred Berman ◽  
Lydia L. Pauli

We were stunned to read in the reply (Pediatrics, 52:754, 1973) by the Committee on Drugs of the American Academy of Pediatrics to our letter, Amphetamines in Epilepsy, that their "thorough" search of the medical literature failed to elicit any documentation of the value of amphetamines in epilepsy. A cursory glance at the literature would at least reveal publications by more than 30 eminent physicians, including Carter, Eisenberg, Gastaut, Glaser, Goldensohn, Lennox, Schmidt and Yahr, in addition to our 28 articles, relative to the use of amphetamines in the management of epilepsy (efficacy and/or alleviation of anticonvulsant-induced drowsiness [references will be supplied upon request]).


PEDIATRICS ◽  
1972 ◽  
Vol 49 (6) ◽  
pp. 923-923
Author(s):  
Robert L. Brent

The suggestion of the Infectious Disease Committee of the American Academy of Pediatrics virtually to eliminate vaccinia immunization in this country is an important decision. Frequently important decisions are made unilaterally without laying the legal and political groundwork for an orderly transition from the old to the new status. The transition is already underway to make the U.S.A. a population susceptible to smallpox. Should we not consider more carefully: (1) The present policies in Russia, China, and other nations with regard to their plans for creating a susceptible population.


PEDIATRICS ◽  
1987 ◽  
Vol 80 (6) ◽  
pp. 949-951
Author(s):  
JOSEPH GREENSHER ◽  
HOWARD C. MOFENSON ◽  
THOMAS R. CARACCIO

Previous well-established guidelines for the management of poisonous ingestions in children are undergoing significant change. The time-honored practice of syrup of ipecac-induced vomiting as the primary means of gastrointestinal decontamination now frequently yields to the administration of activated charcoal. Practitioners and emergency room physicians who are increasingly relying on advice from and participation in treatment by regional poison control centers need to understand the rationale behind what many consider contradictions to accepted teaching. A case in point was a recent letter to the American Academy of Pediatrics from a pediatrician questioning the treatment of an ingestion of poison in a toddler.


PEDIATRICS ◽  
1996 ◽  
Vol 98 (1) ◽  
pp. 164-165 ◽  
Author(s):  
Christian F. Poets

The data presented by Johnson et al suggest that the recommendation to place infants on their back or side, issued by the American Academy of Pediatrics in 1992, has so far had very little effect on the way parents put their infants to sleep. This is particularly disappointing as recent data from Europe and New Zealand demonstrate that child care practices can indeed be influenced very effectively. For example, in Avon, United Kingdom, the proportion of infants usually sleeping in the prone position fell from 59% in 1988 to 2% in 1992.


PEDIATRICS ◽  
1970 ◽  
Vol 45 (6) ◽  
pp. 1041-1042
Author(s):  
Charles M. Schlossman

I wish to protest the recent change of the format of the first page of Pediatrics, from the traditional heading of the journal with the seal of the American Academy of Pediatrics, to the present format which I find esthetically quite disturbing and unappealing. I wish to request that the title page be changed back to its previous format.


PEDIATRICS ◽  
1994 ◽  
Vol 94 (1) ◽  
pp. 133-134
Author(s):  
Gerald H. Katzman

In a previous letter to the editor entitled "Neonatal Person-power,"1 I presented my view as to how the need for neonatologists should be addressed. My conclusion and approach differed from the American Academy of Pediatrics Committee on Fetus and Newborn2 but was in agreement with Dr Robertson's position.3 The reason for the differences in the conclusions related to using calculated ratios of neonatologists to live births or lengths of stay without an orientation to the around-the-clock critical care needs of physiologically unstable neonates.


PEDIATRICS ◽  
1994 ◽  
Vol 94 (1) ◽  
pp. 132-132
Author(s):  
Gerald B. Merenstein

We thank Drs Arroll and Thompson for their interest and comments on the American Academy of Pediatrics Vitamin K Task Force statement. They raise two concerns—the validity of the Golding1 paper suggesting an increased risk of cancer and the appropriateness of recommending the use of oral vitamin K. In both the task force statement2 and in response3 to a previous letter to the editor, we have clearly stated that the risks of cancer from intramuscular vitamin K are unproven and unlikely.


PEDIATRICS ◽  
1994 ◽  
Vol 93 (5) ◽  
pp. 873-874
Author(s):  
Melvin I. Marks ◽  
Caroline B. Hall

Dr Zucker's letter describes concern about the American Academy of Pediatrics (AAP) Committee on Infectious Diseases statement on the use of ribavirin for the treatment of respiratory syncytial virus (RSV) infections (Pediatrics 1993;92:501-504). The Committee developed its recommendations on the basis of the available placebo-controlled prospective double-blind studies. Although these studies contained relatively small numbers of patients, they were controlled and prospective, and all showed a favorable response. The variable course of RSV illnesses and the relatively low mortality rates make clinically meaningful end-points difficult to define and quantitate.


PEDIATRICS ◽  
1970 ◽  
Vol 45 (4) ◽  
pp. 715-716
Author(s):  
Margaret H. D. Smith

For the American Academy of Pediatrics, Committee on Control of Infectious Diseases, Dr. Margaret H. D. Smith commented as follows: The patient reported by Lintermans and Sehynaeve is indeed perplexing, and is hard to clarify in retrospect. Several questions arise: Why was the antituberculosis therapy which the patient was receiving ineffective? The tubercle bacilli recovered in November after 2 to 3 months of treatment with INH and streptomycin were INH resistant. While INH resistance not infrequently develops during therapy in patients with cavitary tuberculosis, where the populations of tubercle bacilli are huge, it rarely if ever develops during treatment in children with primary tuberculosis.


Sign in / Sign up

Export Citation Format

Share Document